Jowell Global Ltd. (JWEL) - Form 20-F Summary
Business Context and Reporting Period
Company: Jowell Global Ltd.
Reporting Period: Fiscal Year Ended December 31, 2025
Business Model: Jowell Global is a Cayman Islands holding company operating primarily through a Variable Interest Entity (VIE) in China. It operates an e-commerce platform (LHH Mall) and a network of authorized retail stores ("Love Home Stores") selling health and nutritional supplements, cosmetics, and household products.
Listing: Nasdaq Capital Market (Symbol: JWEL).
Key Financial Metrics (Fiscal Year 2025)
| Metric | 2025 (USD) | 2024 (USD) |
|---|---|---|
| Total Net Revenues | $165.0 million | $133.0 million |
| Net Loss | $(6.3) million | $(8.0) million |
| Loss from Operations | $(5.0) million | $(8.1) million |
| Gross Margin | 7.0% | 0.9% |
| Cash and Cash Equivalents (End of Period) | $2.7 million | $2.2 million |
| Working Capital | $6.5 million | $10.2 million |
| Accumulated Deficit | $(40.3) million | $(34.0) million |
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 24.1% year-over-year, driven primarily by a 289.1% surge in health and nutritional supplements sales ($130.6 million in 2025 vs. $33.6 million in 2024). This growth was achieved by shifting to lower-priced, high-volume products.
- Product Mix Shift: While supplements grew, revenue from cosmetic products decreased 34.2% and household products decreased 83.4%, reflecting a strategic pivot away from premium brands due to weak consumer demand.
- Profitability Improvement: The net loss narrowed by 21.6% to $6.3 million. Gross margin improved significantly to 7.0% from 0.9% in 2024, aided by the product mix shift and cost management.
- Expense Increases: Total operating expenses rose 20.5% to $170.0 million. Notably, fulfillment expenses increased 303.3% to $8.1 million due to higher sales volume, and share-based compensation increased by $489,000.
- Supplier Concentration: Dependence on a single related-party supplier (Longrich Group) intensified, accounting for approximately 89% of total purchases in 2025, up from 26% in 2024.
Guidance, Outlook, and Risks
Liquidity and Going Concern: The company has incurred recurring losses and an accumulated deficit of $40.3 million. Management has identified a material uncertainty regarding the company's ability to continue as a going concern. Liquidity is supported by approximately $2.7 million in cash, related party loans, and potential equity financing. Management plans to reduce costs and turn profitable within 1-2 years.
Key Risks:
- VIE Structure: Operations rely on contractual arrangements with a Chinese VIE. Changes in PRC regulations could invalidate these arrangements, potentially rendering the company's securities worthless.
- Related Party Transactions: Extreme reliance on Longrich Group (89% of purchases) creates significant conflict of interest and supply chain risks.
- Regulatory Environment: Subject to evolving PRC regulations regarding overseas listings, data security, and foreign investment restrictions.
- Internal Controls: The company identified a material weakness in internal controls over financial reporting due to a lack of in-house accounting personnel with appropriate U.S. GAAP knowledge.
Investor Verification Checklist
- Supplier Dependency: Verify the terms and stability of the relationship with Longrich Group, which supplies nearly 90% of inventory.
- Cash Runway: Assess the sufficiency of the $2.7 million cash balance against operating burn rates and the timeline for profitability.
- VIE Enforceability: Review the legal opinion regarding the enforceability of the VIE agreements under current PRC law.
- Internal Control Remediation: Monitor progress on hiring U.S. GAAP-compliant accounting staff to address the material weakness.
- Product Mix Sustainability: Evaluate whether the shift to low-margin, high-volume health supplements can sustain revenue growth without eroding profitability further.